Literature DB >> 19572149

Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma.

Chunling Zhao1, Lei Gong, Wentong Li, Limei Chen.   

Abstract

PURPOSE: Plk1, belonging to a family of serine/threonine kinases, is involved in spindle formation and chromosome segregation during mitosis and therefore, in the regulation of cell cycle. Plk1 was found to be overexpressed in various human tumors. In the present work, we investigated the expression of human esophageal squamous cell carcinoma (ESCC) to determine whether Plk1 has a role in malignant progress.
METHODS: Immunohistochemistry and Western blotting were performed to define the expressions of Plk1 in ESCC tissues and normal adjacent tissues. Transfection of cells with small interference RNA, growth suppression assay, and Transwell assay were used to determine the potential role of Plk1 in ESCC malignant progress.
RESULTS: Plk1 was overexpressed in 69.6% of the ESCC tissues. In addition, the extent of Plk1 expression was closely correlated with differentiation grades and invasiveness in ESCC. We also found that the downregulation of endogenous Plk1 in human ESSC cell lines Eca-109 and EC9706 significantly decreased cells proliferation and migrating ability.
CONCLUSIONS: Our results show that Plk1 expression is elevated in ESCC tissues and is associated with differentiation grades and invasiveness in ESCC, indicating that overexpression of Plk1 may play an important role in carcinogenesis and malignant progress of ESCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19572149     DOI: 10.1007/s00432-009-0630-4

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  29 in total

1.  Prognostic value of pololike kinase expression in melanomas.

Authors:  K Strebhardt; L Kneisel; C Linhart; A Bernd; R Kaufmann
Journal:  JAMA       Date:  2000-01-26       Impact factor: 56.272

2.  Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma.

Authors:  Yan-Bin Feng; De-Chen Lin; Zhi-Zhou Shi; Xiao-Chun Wang; Xiao-Ming Shen; Yu Zhang; Xiao-Li Du; Man-Li Luo; Xin Xu; Ya-Ling Han; Yan Cai; Zi-Qiang Zhang; Qi-Min Zhan; Ming-Rong Wang
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396

Review 3.  Polo-like kinases: a team that plays throughout mitosis.

Authors:  D M Glover; I M Hagan; A A Tavares
Journal:  Genes Dev       Date:  1998-12-15       Impact factor: 11.361

4.  Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells.

Authors:  Birgit Spänkuch-Schmitt; Jürgen Bereiter-Hahn; Manfred Kaufmann; Klaus Strebhardt
Journal:  J Natl Cancer Inst       Date:  2002-12-18       Impact factor: 13.506

5.  Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck.

Authors:  R Knecht; R Elez; M Oechler; C Solbach; C von Ilberg; K Strebhardt
Journal:  Cancer Res       Date:  1999-06-15       Impact factor: 12.701

Review 6.  Genetic steps in the development of squamous cell carcinoma of the esophagus.

Authors:  A M Mandard; P Hainaut; M Hollstein
Journal:  Mutat Res       Date:  2000-04       Impact factor: 2.433

7.  Cooperative phosphorylation including the activity of polo-like kinase 1 regulates the subcellular localization of cyclin B1.

Authors:  Juping Yuan; Frank Eckerdt; Jürgen Bereiter-Hahn; Elisabeth Kurunci-Csacsko; Manfred Kaufmann; Klaus Strebhardt
Journal:  Oncogene       Date:  2002-11-28       Impact factor: 9.867

8.  Polo-like kinase (Plk) 1: a novel target for the treatment of prostate cancer.

Authors:  Nihal Ahmad
Journal:  FASEB J       Date:  2004-01       Impact factor: 5.191

9.  Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.

Authors:  Birgit Spänkuch-Schmitt; Georg Wolf; Christine Solbach; Sibylle Loibl; Rainald Knecht; Manfred Stegmüller; Gunter von Minckwitz; Manfred Kaufmann; Klaus Strebhardt
Journal:  Oncogene       Date:  2002-05-09       Impact factor: 9.867

10.  Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.

Authors:  Youquan Bu; Zhengmei Yang; Quanhai Li; Fangzhou Song
Journal:  Oncology       Date:  2008-08-20       Impact factor: 2.935

View more
  9 in total

1.  [miR-593 inhibits proliferation of colon cancer cells in vitro by down-regulating PLK1].

Authors:  Jinzhu Ma; Yiping Zhu; Zhen Wang; Jiawei Zan; Long Cao; Zunyong Feng; Senlin Wang; Qian Fan; Liang Yan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-02-28

2.  PLK1 promotes epithelial-mesenchymal transition and metastasis of gastric carcinoma cells.

Authors:  Xiao Peng Cai; Liang Dong Chen; Hai Bin Song; Chun Xiao Zhang; Ze Wei Yuan; Zhen Xian Xiang
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

3.  Quantitative proteome analysis of pluripotent cells by iTRAQ mass tagging reveals post-transcriptional regulation of proteins required for ES cell self-renewal.

Authors:  Robert N O'Brien; Zhouxin Shen; Kiyoshi Tachikawa; Pei Angel Lee; Steven P Briggs
Journal:  Mol Cell Proteomics       Date:  2010-05-31       Impact factor: 5.911

Review 4.  Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications.

Authors:  Ion Cristóbal; Federico Rojo; Juan Madoz-Gúrpide; Jesús García-Foncillas
Journal:  Mol Cell Biol       Date:  2016-05-31       Impact factor: 4.272

5.  PLK1 gene suppresses cell invasion of undifferentiated thyroid carcinoma through the inhibition of CD44v6, MMP-2 and MMP-9.

Authors:  Xing-Guang Zhang; Xiao-Feng Lu; Xiu-Ming Jiao; Bin Chen; Jin-Xiao Wu
Journal:  Exp Ther Med       Date:  2012-09-28       Impact factor: 2.447

6.  The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma.

Authors:  M Dibb; N Han; J Choudhury; S Hayes; H Valentine; C West; Y S Ang; A D Sharrocks
Journal:  Br J Cancer       Date:  2012-10-04       Impact factor: 7.640

Review 7.  Unconventional Functions of Mitotic Kinases in Kidney Tumorigenesis.

Authors:  Pauline Hascoet; Franck Chesnel; Cathy Le Goff; Xavier Le Goff; Yannick Arlot-Bonnemains
Journal:  Front Oncol       Date:  2015-10-27       Impact factor: 6.244

8.  SCF(FBXW7α) modulates the intra-S-phase DNA-damage checkpoint by regulating Polo like kinase-1 stability.

Authors:  Servando Giráldez; Joaquín Herrero-Ruiz; Mar Mora-Santos; Miguel Á Japón; Maria Tortolero; Francisco Romero
Journal:  Oncotarget       Date:  2014-06-30

9.  FOXM1 and polo-like kinase 1 are co-ordinately overexpressed in patients with gastric adenocarcinomas.

Authors:  M Dibb; N Han; J Choudhury; S Hayes; H Valentine; C West; A D Sharrocks; Yeng S Ang
Journal:  BMC Res Notes       Date:  2015-11-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.